Philip Bejon
Director Modernising Medical Microbiology
I was Director of the KEMRI-Wellcome Trust Research Programme up to January 2024, and was based in Kenya for 10 years. I am now based in Oxford, as Director of the Modernising Medical Microbiology Unit, where I work on antimicrobial resistance, bone infection, and pathogen genomics. I continue to work with colleagues based in Kenya on controlled human malaria infection studies, and on evaluations of malaria vaccines in the field, on validating definitions of severe malaria, studies of naturally acquired immunity to malaria, evaluations of Ebola and Yellow Fever vaccines, and on the epidemiology and immunology of COVID in Kenya.
Visit Philip's profile page for Modernising Medical Microbiology
Recent publications
Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020–2025): Clinical Features and Wave Patterns
Journal article
Lambisia AW. et al, (2026), Open Forum Infectious Diseases
Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial
Journal article
Kapulu MC. et al, (2026), Nature Medicine, 32, 178 - 185
Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.
Journal article
Kimathi D. et al, (2026), Lancet (London, England)
R21/Matrix-M protects against dermal but not against venous parasites in a randomised controlled human challenge study
Journal article
Kapulu M. and Bejon P., (2025), Nature Medicine
Nanopore adaptive sampling for bacterial identification from periprosthetic joint replacement tissue
Journal article
Street TL. et al, (2025), Microbial Genomics, 11